January 5, 2016 Off

Midatech in vaccines collaboration with Emergex

By Dino Mustafić

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, has entered into a licensing agreement with Emergex Vaccines Limited, a private UK biotechnology company focused on infectious diseases utilising Midatech’s gold nanoparticle technology.